Business Description
Redwood Pharma AB
ISIN : SE0021512134
Compare
Compare
Traded in other countries / regions
REDW.Sweden9JV0.Germany IPO Date
2016-06-15Description
Redwood Pharma AB is engaged in developing new ophthalmic pharmaceutical therapies for unmet market needs. Its development product is a new therapy to treat chronic Dry Eye Disease (DED) in post-menopausal women.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.87 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 26.7 | |||||
3-Year EPS without NRI Growth Rate | 27.1 | |||||
3-Year FCF Growth Rate | 24.7 | |||||
3-Year Book Growth Rate | -16.1 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 33 | |||||
9-Day RSI | 40.58 | |||||
14-Day RSI | 44.37 | |||||
6-1 Month Momentum % | -80.62 | |||||
12-1 Month Momentum % | -96.91 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.49 | |||||
Quick Ratio | 1.49 | |||||
Cash Ratio | 0.55 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -28.7 | |||||
Shareholder Yield % | -323.71 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -93.21 | |||||
ROA % | -82.62 | |||||
ROIC % | -109.36 | |||||
ROC (Joel Greenblatt) % | -412.89 | |||||
ROCE % | -86.86 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.25 | |||||
Price-to-Tangible-Book | 0.71 | |||||
EV-to-EBIT | -0.2 | |||||
EV-to-EBITDA | -0.21 | |||||
EV-to-FCF | -0.24 | |||||
Price-to-Net-Current-Asset-Value | 3.94 | |||||
Earnings Yield (Greenblatt) % | -514.64 | |||||
FCF Yield % | -405.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Redwood Pharma AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | |||
EPS (TTM) (kr) | -7.935 | ||
Beta | 0 | ||
Volatility % | 80.5 | ||
14-Day RSI | 44.37 | ||
14-Day ATR (kr) | 0.722223 | ||
20-Day SMA (kr) | 1.63135 | ||
12-1 Month Momentum % | -96.91 | ||
52-Week Range (kr) | 0.506 - 31.705973 | ||
Shares Outstanding (Mil) | 2.65 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Redwood Pharma AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Redwood Pharma AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Redwood Pharma AB Frequently Asked Questions
What is Redwood Pharma AB(OSTO:REDW)'s stock price today?
The current price of OSTO:REDW is kr1.07. The 52 week high of OSTO:REDW is kr31.71 and 52 week low is kr0.51.
When is next earnings date of Redwood Pharma AB(OSTO:REDW)?
The next earnings date of Redwood Pharma AB(OSTO:REDW) is 2024-08-29.
Does Redwood Pharma AB(OSTO:REDW) pay dividends? If so, how much?
Redwood Pharma AB(OSTO:REDW) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |